Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000919574-25-000967·MARINUS PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
MARINUS PHARMACEUTICALS INC
Common Stock, par value $0.001 per share · CUSIP: 56854Q200
Event date: 2025-02-07
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- SUVRETTA CAPITAL MANAGEMENT, LLC
Shares: 3,022,612.00 · Class: 5.5%
- Averill Master Fund, Ltd.
Shares: 3,022,612.00 · Class: 5.5%
- Aaron Cowen
Shares: 3,022,612.00 · Class: 5.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-000967
- Form type
- SCHEDULE 13G
- Filer
- MARINUS PHARMACEUTICALS, INC.
- CIK
- CIK 1267813
- Filed
- Feb 11, 2025
- Reporting period
- Feb 07, 2025
- Description
- Schedule 13G beneficial ownership